ArticleHaematologica2026

Intensive induction therapy with FLAG-idarubicinvenetoclax for fit older high-risk patients with acute myeloid leukemia.

Avraham Frisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.